# A Study in Healthy Men to Test How BI 685509 is Processed in the Body

> **NCT05515328** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [¹⁴C] BI 685509 formulation 1
- **DRUG:** [¹⁴C] BI 685509 formulation 2
- **DRUG:** BI 685509 formulation 3

## Key facts

- **NCT ID:** NCT05515328
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-08
- **Primary completion:** 2022-11-17
- **Final completion:** 2022-11-17
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05515328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05515328, "A Study in Healthy Men to Test How BI 685509 is Processed in the Body". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05515328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*